XML 24 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Common Stock
Preferred Stock
Preferred Stock
Preferred Stock
Common Stock
Common Stock
Common Stock
Additional Paid-in- Capital
Additional Paid-in- Capital
Preferred Stock
Additional Paid-in- Capital
Common Stock
Treasury Stock
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2019 $ 636,590 $ (1,770)     $ 0   $ 272   $ 473,251     $ (67,069) $ 229,030 $ (1,770) $ 1,106
Beginning balance, common stock (in shares) at Dec. 31, 2019             24,964,961                
Beginning balance, treasury stock (in shares) at Dec. 31, 2019                       2,198,681      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock, net of issuance costs (in shares)               630,268              
Issuance of stock, net of issuance costs     $ 42,364 $ 13,942   $ 45,000   $ 7   $ (2,636) $ 13,935        
Issuance of restricted stock awards (in shares)             138,417                
Issuance of restricted stock awards 0           $ 1   (1)            
Stock based compensation 4,618               4,618            
Forfeiture of restricted stock awards (in shares)             (6,067)         (6,067)      
Forfeiture of restricted stock awards 0               211     $ (211)      
Stock option exercises, net (in shares)             19,394                
Stock option exercises, net (227)               (227)            
Purchase of treasury stock (in shares)             (878,755)         (878,755)      
Purchase of treasury stock (35,772)                     $ (35,772)      
Preferred stock dividends (1,701)                       (1,701)    
Net income 64,024                       64,024    
Other comprehensive income (loss) 4,713                           4,713
Ending balance at Dec. 31, 2020 726,781       45,000   $ 280   489,151     $ (103,052) 289,583   5,819
Ending balance, common stock (in shares) at Dec. 31, 2020             24,868,218                
Ending balance, treasury stock (in shares) at Dec. 31, 2020                       3,083,503      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of restricted stock awards (in shares)             241,014                
Issuance of restricted stock awards 0           $ 2   (2)            
Stock based compensation 20,315               20,315            
Forfeiture of restricted stock awards (in shares)             (5,129)         (5,129)      
Forfeiture of restricted stock awards 0               450     $ (450)      
Stock option exercises, net (in shares)             59,844                
Stock option exercises, net $ 577           $ 1   576            
Issuance of common stock pursuant to the employee stock purchase plan (in shares) 9,101           9,101                
Issuance of common stock pursuant to the employee stock purchase plan $ 449               449            
Purchase of treasury stock (in shares)             (14,169)         (14,169)      
Purchase of treasury stock (1,241)                     $ (1,241)      
Preferred stock dividends (3,206)                       (3,206)    
Net income 112,974                       112,974    
Other comprehensive income (loss) 2,215                           2,215
Ending balance at Dec. 31, 2021 $ 858,864       45,000   $ 283   510,939     $ (104,743) 399,351   8,034
Ending balance, common stock (in shares) at Dec. 31, 2021 25,158,879           25,158,879                
Ending balance, treasury stock (in shares) at Dec. 31, 2021                       3,102,801      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of restricted stock awards (in shares)             12,471                
Vesting of performance stock units (in shares)             20,996                
Stock based compensation $ 21,176               21,176            
Forfeiture of restricted stock awards (in shares)             (19,186)         (19,186)      
Forfeiture of restricted stock awards 0               1,201     $ (1,201)      
Stock option exercises, net (in shares)             2,053                
Stock option exercises, net $ (74)               (74)            
Issuance of common stock pursuant to the employee stock purchase plan (in shares) 24,516           24,516                
Issuance of common stock pursuant to the employee stock purchase plan $ 1,548               1,548            
Purchase of treasury stock (in shares)             (1,146,144)         (1,146,144)      
Purchase of treasury stock (76,714)                     $ (76,714)      
Preferred stock dividends (3,206)                       (3,206)    
Net income 102,311                       102,311    
Other comprehensive income (loss) (14,934)                           (14,934)
Ending balance at Dec. 31, 2022 $ 888,971       $ 45,000   $ 283   $ 534,790     $ (182,658) $ 498,456   $ (6,900)
Ending balance, common stock (in shares) at Dec. 31, 2022 24,053,585           24,053,585                
Ending balance, treasury stock (in shares) at Dec. 31, 2022                       4,268,131